¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Transient Receptor Potential Channels"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
labyrinthine receptor
¹Ì·Î¼ö¿ë±â
muscarinic receptor
¹«½ºÄ«¸°¼ö¿ëü
neuromuscular receptor
½Å°æ±Ù(À°)¼ö¿ëü
nicotinic receptor
´ÏÄÚÆ¾¼ö¿ëü
olfactory receptor
Èİ¢¼ö¿ë±â
opiate receptor
¾ÆÆíÁ¦¼ö¿ëü
opioid receptor
¾ÆÆíÀ¯»çÁ¦¼ö¿ëü
postsynaptic receptor
½Ã³À½ºÈļö¿ëü, ¿¬Á¢Èļö¿ëü
prejunctional receptor
Á¢ÇÕÀü¼ö¿ëü
pressor receptor
½Â¾Ð¼ö¿ë±â
paciniform receptor
ÆÄÄ¡´ÏÇü¼ö¿ë±â
progesterone receptor
ÇÁ·Î°Ô½ºÅ׷мö¿ëü
receptor
1. ¼ö¿ëü 2. ¼ö¿ë±â
receptor autoradiography
¼ö¿ëüÀÚ°¡Á¶Á÷¹æ»ç¼±ÃÔ¿µ(¼ú)
receptor binding
¼ö¿ëü°áÇÕ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
receptor destroying enzyme
¼ö¿ëüÆÄ±«È¿¼Ò
free receptor
À¯¸®¼ö¿ëü
gustatory receptor
¹Ì°¢¼ö¿ëü
receptor gradient
¼ö¿ë´Ü¹é±â¿ï±â, ¼ö¿ë´Ü¹é°æ»ç
hairy skin receptor
ÅÐÇǺμö¿ëü
heat receptor
¿¼ö¿ëü
histamine receptor
È÷½ºÅ¸¹Î¼ö¿ëü
homing receptor
±Í¼Ò¼ö¿ëü
receptor hypothesis
¼ö¿ëü°¡¼³
immunoglobulin adhesion receptor
¸é¿ª±Û·ÎºÒ¸°ºÎÂø¼ö¿ëü
insulin receptor
Àν¶¸°¼ö¿ëü
interferon receptor
ÀÎÅÍÆä·Ð¼ö¿ëü
internalization receptor
³»È¼ö¿ëü
irritant receptor
Àڱؼö¿ëü
receptor imaging
¼ö¿ëü¿µ»ó, ¼ö¿ëü¿µ»óÈ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
polarizing potential
ºÐ±ØÀü¾Ð(¡ï³äâ).
positive after potential
¾ç¼ºÈÄÀüÀ§(åÕàõýï³êÈ).
postsynaptic potential
½Ã³³½ºÈÄÀü¾Ð.
potential
˟ˤ
potential acuity meter
ÀáÀç½Ã·ÂÃøÁ¤±â
potential barrier
ÀüÀ§À庮
potential difference
Àü¾ÐÂ÷, ÀüÀ§Â÷.
presynaptic potential
½Ã³³½ºÀüÀüÀ§.
redox potential
»êÈȯ¿øÀüÀ§(ß«ûùü»êª ï³êÈ).
reduction potential
ȯ¿øÀüÀ§.
reinnervation potential
½Å°æÀçÁö¹èÀüÀ§(ãêÌèî¢ò¨ÛÕï³êÈ).
A1 receptor
A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
A2 receptor
A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
CR1 => complement receptor 1
º¸Ã¼¼ö¿ëü 1
CR2 => complement receptor 2
º¸Ã¼¼ö¿ëü 2
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
adrenergic receptor
¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â,°¨¼öü)
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
³²¼ºÈ£¸£¸ó ¼ö¿ëü
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü.
benzodiazepine receptor agonists(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ÀÛ¿ëÁ¦
benzodiazepine receptor antagonist(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ±æÇ×Á¦
benzodiazepine receptor(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü
beta adrenergic receptor
º£Å¸¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼öü)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½